Technology | 2016.04.12
Gene-editing company Intellia files for $120 million IPO - MarketWatch
| Gene- editing company Intellia files for $120 million IPO MarketWatch Intellia Therapeuticals Inc. has filed an initial public offering for up to $120 million worth of shares, according to a filing Monday. The gene- editing company said its technologies have broad applications, with some potentially curing genetic ... |
For more information, please visit
http://news.google.com/news/url?sa=t&fd=[...]for-120-million-ipo-2016-04-11
